226 Objectives: Right ventricular (RV) dysfunction is recognized as a major prognostic factor
in left-sided heart failure (HF). However, the contribution of RV dysfunction and metabolic …

Abstract Purpose Dynamic 18 F-fluorodeoxyglucose (FDG) PET can be used to
quantitatively assess the rate of myocardial glucose uptake (MRGlu). The aim of this study …

Aims In dilated cardiomyopathy (DCM), there are limited data on right ventricular (RV)
glucose metabolism assessed by [18 F] fludeoxyglucose positron emission tomography (18 …

Background—Left heart failure is characterized by alterations in metabolic substrate
utilization, and metabolic modulation may be a future strategy in the management of heart …

1782 Objectives (18) F-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) is
assumed a useful method for evaluating the viability of the myocardium. However, the …

Background: Imaging modalities such as dobutamine-echocardiography, magnetic
resonance imaging and PET have been able to predict functional racovely of the …

Purpose Myocardial glucose utilization (MGU) is altered in various heart diseases. The aim
of this study was to quantitatively assess regional myocardial glucose utilization in patients …

3378 Introduction: The aim of the study was to determine the prognostic value of the
myocardial viability and glucose metabolism derived from dynamic cardiac FDG PET/CT in …

Objective To explore the relationship between myocardial glucose metabolism in the right
heart and cardiac function in patients with idiopathic dilated cardiomyopathy (IDCM) …

1539 Objectives High free fatty acid with reduced glucose utilization in diabetes mellitus
(DM) impairs cardiac function. In this study, we investigated the kinetics of FDG and the …